← Leaderboards
Erik Selsing
Tufts University Boston
$4,990,158
Attributed
$4,990,158
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $609.5K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$4,990,158 · 4
By mechanism
R01$4,443,863 · 2
R21$381,295 · 1
R03$165,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Tufts University Boston
Same institution · by research overlap
- David A Thorley-Lawson$13,752,380
- Stephen C Bunnell$3,800,424
- Thereza Imanishi-Kari$3,700,996
- Brigitte T. Huber$10,217,193
- Aaron M Harris$230,763
Others in their field
Top investigators on “Gene Targeting”
- David Heimbrook · Leidos Biomedical Research, Inc.$205,122,388
- Richard A Gibbs · Baylor College Of Medicine$161,086,449
- Barton F Haynes · Duke University$98,448,044
- Andrzej Joachimiak Joachimiak · University Of Chicago$94,692,413
- Eric Martin McDade · Washington University$94,632,845
- Stephen S. Rich · University Of Alabama At Birmingham$84,483,911
Research focus
Gene TargetingLaboratory MouseB LymphocyteImmunoglobulin GenesGenetically Modified AnimalsGene RearrangementImmunoglobulin Class SwitchingHumoral ImmunityAntibodiesB-LymphocytesAffectGene Deletion MutationImmunoglobulin IsotypesImmunityImmunoglobulin AGenetic RecombinationChromatin StructureComplexDna DamageGenetic AnalysisAmino Acid SequenceBiological ModelsChromosomal TranslocationConstant Region Gene
Grant awards (18)
Testing a role for activation-induced deaminase in Omenns syndrome B-cell autoimm$82,500
R03 · FY2012 · AI · contact PI
Testing a role for activation-induced deaminase in Omenns syndrome B-cell autoimm$82,500
R03 · FY2011 · AI · contact PI
Immunity in Transgenic Mice$385,463
R01 · FY2010 · AI · contact PI
Immunity in Transgenic Mice$389,356
R01 · FY2009 · AI · contact PI
Immunity in Transgenic Mice$389,356
R01 · FY2008 · AI · contact PI
Immunity in Transgenic Mice$396,896
R01 · FY2007 · AI · contact PI
Immunity in Transgenic Mice$408,750
R01 · FY2006 · AI · contact PI
Transgenic Mice for Sensing Bioweapons$200,732
R21 · FY2006 · RR · contact PI
Immunity in Transgenic Mice$317,000
R01 · FY2005 · AI
Transgenic Mice for Sensing Bioweapons$180,563
R21 · FY2005 · RR
Immunity in Transgenic Mice$317,000
R01 · FY2004 · AI
Immunity in Transgenic Mice$317,000
R01 · FY2003 · AI
FUNCTIONS OF ANTIBODY SWITCH REGIONS$208,750
R01 · FY2003 · AI
Immunity in Transgenic Mice$301,150
R01 · FY2002 · AI
FUNCTIONS OF ANTIBODY SWITCH REGIONS$208,750
R01 · FY2002 · AI
Immunity in Transgenic Mice$285,300
R01 · FY2001 · AI
FUNCTIONS OF ANTIBODY SWITCH REGIONS$208,750
R01 · FY2001 · AI
IMMUNITY IN TRANSGENIC MICE$310,342
R01 · FY2000 · AI